These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12492247)

  • 21. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
    Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
    J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy.
    Tishler M; Caspi D; Halperin Z; Baratz M; Moshkowitz M; Yaron M
    Rheumatol Int; 1992; 12(1):39-41. PubMed ID: 1598500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
    Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Guérette B; Mozaffarian N
    J Rheumatol; 2013 Sep; 40(9):1487-97. PubMed ID: 23818718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment.
    Fukushima M; Katayama Y; Yokose N; Kura Y; Sawada U; Kotani A; Yoshino A
    Br J Neurosurg; 2013 Dec; 27(6):824-6. PubMed ID: 23705580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate.
    Park SH; Choe JY; Kim SK
    Joint Bone Spine; 2010 Dec; 77(6):588-92. PubMed ID: 20471892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate.
    Kotrych D; Dziedziejko V; Safranow K; Pawlik A
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3037-40. PubMed ID: 26367725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
    Kujala GA; Shamma'a JM; Chang WL; Brick JE
    Arthritis Rheum; 1990 Jul; 33(7):1037-41. PubMed ID: 2369419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
    J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis.
    Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH
    J Pediatr; 1999 Jan; 134(1):47-52. PubMed ID: 9880448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate-associated primary hepatic lymphoma and cranial neuropathy in a patient with rheumatoid arthritis: A case report with clinical follow-up over a 7-year period.
    Park JE; Lee KM; Choi HY; Ahn SE; You MW
    Medicine (Baltimore); 2019 Apr; 98(17):e14997. PubMed ID: 31027052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
    Dubey L; Chatterjee S; Ghosh A
    Indian J Pharmacol; 2016; 48(5):591-594. PubMed ID: 27721549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
    Rau R; Karger T; Herborn G; Frenzel H
    J Rheumatol; 1989 Apr; 16(4):489-93. PubMed ID: 2473207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.